US Stock MarketDetailed Quotes

NRXP NRX Pharmaceuticals

Watchlist

2.3400
+0.0100+0.43%

Close Jul 22 16:00 ET

2.3000
-0.0400-1.71%

Post 16:15 ET

25.04MMarket Cap-759P/E (TTM)

NRX Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

39.71%-3.67M

45.52%-21.66M

61.63%-3.19M

27.16%-4.56M

47.18%-7.81M

41.34%-6.09M

-5.44%-39.76M

26.26%-8.32M

47.84%-6.27M

-29.81%-14.79M

Net income from continuing operations

40.86%-6.53M

24.16%-30.15M

57.70%-4.33M

33.26%-6.06M

-24.85%-8.72M

17.91%-11.04M

57.28%-39.75M

66.32%-10.24M

75.48%-9.08M

-5,867.52%-6.98M

Operating gains losses

175.00%9K

92.16%-20K

136.84%7K

-170.27%-26K

109.48%11K

92.36%-12K

85.93%-255K

97.81%-19K

-99.78%37K

99.33%-116K

Depreciation and amortization

0.00%1K

25.00%5K

0.00%1K

100.00%2K

0.00%1K

100.00%4K

--1K

0.00%1K

Other non cash items

-82.05%318K

172.53%2.96M

-117.23%-87K

--359K

136.80%913K

184.34%1.77M

-107.51%-4.08M

-97.39%505K

--0

-147.62%-2.48M

Change In working capital

-8.30%2.29M

638.77%5.16M

261.49%2.42M

-63.72%812K

90.90%-564K

-37.51%2.49M

114.27%699K

171.43%670K

259.86%2.24M

-81.71%-6.2M

-Change in prepaid assets

-49.08%250K

581.01%3.04M

83.23%1.49M

-51.90%632K

109.61%431K

-71.57%491K

86.86%-632K

-34.65%811K

209.41%1.31M

6.56%-4.48M

-Change in payables and accrued expense

1.70%2.04M

59.58%2.12M

763.83%936K

-80.52%180K

42.02%-995K

-11.53%2M

244.67%1.33M

93.53%-141K

564.32%924K

-223.72%-1.72M

Cash from discontinued investing activities

Operating cash flow

39.71%-3.67M

45.52%-21.66M

61.63%-3.19M

27.16%-4.56M

47.18%-7.81M

41.34%-6.09M

-5.44%-39.76M

26.26%-8.32M

47.84%-6.27M

-29.81%-14.79M

Investing cash flow

Cash flow from continuing investing activities

70.00%-3K

0.00%1K

60.00%-2K

166.67%2K

-33.33%-4K

-42.86%-10K

-25.00%-5K

0.00%-3K

Net PPE purchase and sale

--0

70.00%-3K

0.00%1K

60.00%-2K

166.67%2K

-33.33%-4K

-42.86%-10K

--1K

-25.00%-5K

0.00%-3K

Cash from discontinued investing activities

Investing cash flow

--0

70.00%-3K

0.00%1K

60.00%-2K

166.67%2K

-33.33%-4K

-42.86%-10K

--1K

-25.00%-5K

0.00%-3K

Financing cash flow

Cash flow from continuing financing activities

-84.48%395K

-80.75%6.2M

-111.03%-1.12M

-5,260.71%-1.5M

829.42%6.27M

-88.93%2.55M

-49.23%32.21M

1,012,100.00%10.12M

-100.07%-28K

-107.47%-860K

Net issuance payments of debt

---2.16M

-132.54%-3.09M

-111.14%-1.12M

---2.67M

--696K

--0

844.67%9.5M

1,001,900.00%10.02M

--0

----

Net common stock issuance

0.20%2.55M

-64.22%8.12M

--0

1,730.70%5.58M

-88.93%2.55M

-38.62%22.7M

--92K

-100.10%-28K

-121.90%-342K

Net preferred stock issuance

----

--1.17M

--0

----

--0

----

Proceeds from stock option exercised by employees

----

--0

----

-99.94%10K

----

Cash from discontinued financing activities

Financing cash flow

-84.48%395K

-80.75%6.2M

-111.03%-1.12M

-5,260.71%-1.5M

829.42%6.27M

-88.93%2.55M

-49.23%32.21M

1,012,100.00%10.12M

-100.07%-28K

-107.47%-860K

Net cash flow

Beginning cash position

-77.09%4.6M

-27.35%20.05M

-51.22%8.9M

-39.02%14.97M

-58.94%16.51M

-27.35%20.05M

1,384.94%27.61M

-53.07%18.25M

83.39%24.55M

202.93%40.2M

Current changes in cash

7.67%-3.28M

-104.73%-15.46M

-338.61%-4.31M

3.68%-6.07M

90.18%-1.54M

-128.17%-3.55M

-129.33%-7.55M

116.00%1.81M

-124.70%-6.3M

-13,712.17%-15.65M

End cash Position

-92.01%1.32M

-77.09%4.6M

-51.22%8.9M

-39.02%14.97M

-58.94%16.51M

-27.35%20.05M

-53.07%18.25M

83.39%24.55M

Free cash flow

39.75%-3.67M

45.53%-21.66M

61.63%-3.19M

27.19%-4.57M

47.21%-7.81M

41.32%-6.09M

-5.45%-39.77M

26.27%-8.32M

47.82%-6.27M

-29.81%-14.79M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	39.71%-3.67M	45.52%-21.66M	61.63%-3.19M	27.16%-4.56M	47.18%-7.81M	41.34%-6.09M	-5.44%-39.76M	26.26%-8.32M	47.84%-6.27M	-29.81%-14.79M
Net income from continuing operations	40.86%-6.53M	24.16%-30.15M	57.70%-4.33M	33.26%-6.06M	-24.85%-8.72M	17.91%-11.04M	57.28%-39.75M	66.32%-10.24M	75.48%-9.08M	-5,867.52%-6.98M
Operating gains losses	175.00%9K	92.16%-20K	136.84%7K	-170.27%-26K	109.48%11K	92.36%-12K	85.93%-255K	97.81%-19K	-99.78%37K	99.33%-116K
Depreciation and amortization	0.00%1K	25.00%5K	0.00%1K	100.00%2K	0.00%1K	0.00%1K	100.00%4K	--1K	0.00%1K	0.00%1K
Other non cash items	-82.05%318K	172.53%2.96M	-117.23%-87K	--359K	136.80%913K	184.34%1.77M	-107.51%-4.08M	-97.39%505K	--0	-147.62%-2.48M
Change In working capital	-8.30%2.29M	638.77%5.16M	261.49%2.42M	-63.72%812K	90.90%-564K	-37.51%2.49M	114.27%699K	171.43%670K	259.86%2.24M	-81.71%-6.2M
-Change in prepaid assets	-49.08%250K	581.01%3.04M	83.23%1.49M	-51.90%632K	109.61%431K	-71.57%491K	86.86%-632K	-34.65%811K	209.41%1.31M	6.56%-4.48M
-Change in payables and accrued expense	1.70%2.04M	59.58%2.12M	763.83%936K	-80.52%180K	42.02%-995K	-11.53%2M	244.67%1.33M	93.53%-141K	564.32%924K	-223.72%-1.72M
Cash from discontinued investing activities
Operating cash flow	39.71%-3.67M	45.52%-21.66M	61.63%-3.19M	27.16%-4.56M	47.18%-7.81M	41.34%-6.09M	-5.44%-39.76M	26.26%-8.32M	47.84%-6.27M	-29.81%-14.79M
Investing cash flow
Cash flow from continuing investing activities	0	70.00%-3K	0.00%1K	60.00%-2K	166.67%2K	-33.33%-4K	-42.86%-10K	1K	-25.00%-5K	0.00%-3K
Net PPE purchase and sale	--0	70.00%-3K	0.00%1K	60.00%-2K	166.67%2K	-33.33%-4K	-42.86%-10K	--1K	-25.00%-5K	0.00%-3K
Cash from discontinued investing activities
Investing cash flow	--0	70.00%-3K	0.00%1K	60.00%-2K	166.67%2K	-33.33%-4K	-42.86%-10K	--1K	-25.00%-5K	0.00%-3K
Financing cash flow
Cash flow from continuing financing activities	-84.48%395K	-80.75%6.2M	-111.03%-1.12M	-5,260.71%-1.5M	829.42%6.27M	-88.93%2.55M	-49.23%32.21M	1,012,100.00%10.12M	-100.07%-28K	-107.47%-860K
Net issuance payments of debt	---2.16M	-132.54%-3.09M	-111.14%-1.12M	---2.67M	--696K	--0	844.67%9.5M	1,001,900.00%10.02M	--0	----
Net common stock issuance	0.20%2.55M	-64.22%8.12M	--0	--0	1,730.70%5.58M	-88.93%2.55M	-38.62%22.7M	--92K	-100.10%-28K	-121.90%-342K
Net preferred stock issuance	----	--1.17M	--0	----	----	----	--0	--0	----	----
Proceeds from stock option exercised by employees	----	--0	----	----	----	----	-99.94%10K	----	----	----
Cash from discontinued financing activities
Financing cash flow	-84.48%395K	-80.75%6.2M	-111.03%-1.12M	-5,260.71%-1.5M	829.42%6.27M	-88.93%2.55M	-49.23%32.21M	1,012,100.00%10.12M	-100.07%-28K	-107.47%-860K
Net cash flow
Beginning cash position	-77.09%4.6M	-27.35%20.05M	-51.22%8.9M	-39.02%14.97M	-58.94%16.51M	-27.35%20.05M	1,384.94%27.61M	-53.07%18.25M	83.39%24.55M	202.93%40.2M
Current changes in cash	7.67%-3.28M	-104.73%-15.46M	-338.61%-4.31M	3.68%-6.07M	90.18%-1.54M	-128.17%-3.55M	-129.33%-7.55M	116.00%1.81M	-124.70%-6.3M	-13,712.17%-15.65M
End cash Position	-92.01%1.32M	-77.09%4.6M	-77.09%4.6M	-51.22%8.9M	-39.02%14.97M	-58.94%16.51M	-27.35%20.05M	-27.35%20.05M	-53.07%18.25M	83.39%24.55M
Free cash flow	39.75%-3.67M	45.53%-21.66M	61.63%-3.19M	27.19%-4.57M	47.21%-7.81M	41.32%-6.09M	-5.45%-39.77M	26.27%-8.32M	47.82%-6.27M	-29.81%-14.79M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall